ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents

被引：79
作者：
Couper, Jennifer J. [1 ,2 ]
Haller, Michael J. [3 ]
Greenbaum, Carla J. [4 ]
Ziegler, Anette-Gabriele [5 ,6 ]
Wherrett, Diane K. [7 ]
Knip, Mikael [8 ]
Craig, Maria E. [9 ,10 ,11 ]
机构：
[1] Womens & Childrens Hosp, Dept Diabet & Endocrinol, Adelaide, SA, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Florida, Dept Pediat, Div Endocrinol, Gainesville, FL USA
[4] Benaroya Res Inst, Seattle, WA USA
[5] Tech Univ Munich, Klinikum Rechts Isar, Helmholtz Zentrum Munchen, Inst Diabet Res, Munich, Germany
[6] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Munich, Germany
[7] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Endocrinol, Toronto, ON, Canada
[8] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[9] Childrens Hosp Westmead, Dept Diabet & Endocrinol, Sydney, NSW, Australia
[10] Univ Sydney, Discipline Pediat & Child Hlth, Sydney, NSW, Australia
[11] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
来源：
PEDIATRIC DIABETES | 2018年 / 19卷
关键词：
BETA-CELL FUNCTION; HYDROLYZED INFANT FORMULA; C-PEPTIDE; HIGH-RISK; COMBINATION THERAPY; ISLET AUTOIMMUNITY; PARTIAL REMISSION; GENETIC RISK; DOUBLE-BLIND; IMMUNE-RESPONSES;
D O I：
10.1111/pedi.12734
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：20 / 27
页数：8
相关论文
共 103 条
  • [51] Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
    Moran, Antoinette
    Bundy, Brian
    Becker, Dorothy J.
    DiMeglio, Linda A.
    Gitelman, Stephen E.
    Goland, Robin
    Greenbaum, Carla J.
    Herold, Kevan C.
    Marks, Jennifer B.
    Raskin, Philip
    Sanda, Srinath
    Schatz, Desmond
    Wherrett, Diane K.
    Wilson, Darrell M.
    Krischer, Jeffrey P.
    Skyler, Jay S.
    Pickersgill, Linda
    de Koning, Eelco
    Ziegler, Anette-G
    Boeehm, Bernhard
    Badenhoop, Klaus
    Schloot, Nanette
    Bak, Jens Friis
    Pozzilli, Paolo
    Mauricio, Didac
    Donath, Marc Y.
    Castano, Luis
    Waegner, Ana
    Lervang, Hans Henrik
    Perrild, Hans
    Mandrup-Poulsen, Thomas
    [J]. LANCET, 2013, 381 (9881) : 1905 - 1915
  • [52] New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes
    Mortensen, Henrik B.
    Hougaard, Philip
    Swift, Peter
    Hansen, Lars
    Holl, Reinhard W.
    Hoey, Hilary
    Bjoerndalen, Hilde
    de Beaufort, Carine
    Chiarelli, Francesco
    Danne, Thomas
    Schoenle, Eugen J.
    Aman, Jan
    [J]. DIABETES CARE, 2009, 32 (08) : 1384 - 1390
  • [53] Emerging Effects of Early Environmental Factors over Genetic Background for Type 1 Diabetes Susceptibility: Evidence from a Nationwide Italian Twin Study
    Nistico, Lorenza
    Iafusco, Dario
    Galderisi, Alfonso
    Fagnani, Corrado
    Cotichini, Rodolfo
    Toccaceli, Virgilia
    Stazi, Maria Antonietta
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (08) : E1483 - E1491
  • [54] Noble JA, 1996, AM J HUM GENET, V59, P1134
  • [55] Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes
    Norris, Jill M.
    Yin, Xiang
    Lamb, Molly M.
    Barriga, Katherine
    Seifert, Jennifer
    Hoffman, Michelle
    Orton, Heather D.
    Báron, Anna E.
    Clare-Salzler, Michael
    Chase, H. Peter
    Szabo, Nancy J.
    Erlich, Henry
    Eisenbarth, George S.
    Rewers, Marian
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (12): : 1420 - 1428
  • [56] Timing of initial cereal exposure in infancy and risk of islet autoimmunity
    Norris, JM
    Barriga, K
    Klingensmith, G
    Hoffman, M
    Eisenbarth, GS
    Erlich, HA
    Rewers, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1713 - 1720
  • [57] A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults
    Oram, Richard A.
    Patel, Kashyap
    Hill, Anita
    Shields, Beverley
    McDonald, Timothy J.
    Jones, Angus
    Hattersley, Andrew T.
    Weedon, Michael N.
    [J]. DIABETES CARE, 2016, 39 (03) : 337 - 344
  • [58] The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
    Oram, Richard A.
    Jones, Angus G.
    Besser, Rachel E. J.
    Knight, Bridget A.
    Shields, Beverley M.
    Brown, Richard J.
    Hattersley, Andrew T.
    McDonald, Timothy J.
    [J]. DIABETOLOGIA, 2014, 57 (01) : 187 - 191
  • [59] Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
    Orban, Tihamer
    Bundy, Brian
    Becker, Dorothy J.
    DiMeglio, Linda A.
    Gitelman, Stephen E.
    Goland, Robin
    Gottlieb, Peter A.
    Greenbaum, Carla J.
    Marks, Jennifer B.
    Monzavi, Roshanak
    Moran, Antoinette
    Peakman, Mark
    Raskin, Philip
    Russell, William E.
    Schatz, Desmond
    Wherrett, Diane K.
    Wilson, Darrell M.
    Krischer, Jeffrey P.
    Skyler, Jay S.
    [J]. DIABETES CARE, 2014, 37 (04) : 1069 - 1075
  • [60] Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
    Orban, Tihamer
    Bundy, Brian
    Becker, Dorothy J.
    DiMeglio, Linda A.
    Gitelman, Stephen E.
    Goland, Robin
    Gottlieb, Peter A.
    Greenbaum, Carla J.
    Marks, Jennifer B.
    Monzavi, Roshanak
    Moran, Antoinette
    Raskin, Philip
    Rodriguez, Henry
    Russell, William E.
    Schatz, Desmond
    Wherrett, Diane
    Wilson, Darrell M.
    Krischer, Jeffrey P.
    Skyler, Jay S.
    [J]. LANCET, 2011, 378 (9789) : 412 - 419
12345678910